Gene-Disorder Association · Article
Gene
DTNBP1Dystrobrevin Binding Protein 1
×
First reported
2003
Supporting publications
88
Manually curatedApproved treatment annotated
Association Review
In brief
The association between DTNBP1 (Dystrobrevin Binding Protein 1) and Schizophrenia is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
15
Compounds
2
Trials
94of 202 via DTNBP1 compounds
Publications
88
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
1 source summary
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Schizophrenia
The disorder
13 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Phenotype
Clinical features
6 clinical features
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access
06
Interventions
Therapeutics
2 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
07
Human studies
Clinical trials
202 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
88 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
09
Provenance
References & sources
15 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access